Authors: Kemper, CA Witt, MD Keiser, PH Dube, MP Forthal, DN Leibowitz, M Smith, DS Rigby, A Hellmann, NS Lie, YS Leedom, J Richman, D McCutchan, JA Haubrich, R

Citation: Ca. Kemper et al., Sequencing of protease inhibitor therapy: insights from an analysis of HIVphenotypic resistance in patients failing protease inhibitors, AIDS, 15(5), 2001, pp. 609-615

Authors: Morse, GD Reichman, RC Fischl, MA Para, M Leedom, J Powderly, W Demeter, LM Resnick, L Bassiakos, Y Timpone, J Cox, S Batts, D

Citation: Gd. Morse et al., Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies, ANTIVIR RES, 45(1), 2000, pp. 47-58